MolNFT v1 · #186688 · protein
Human malate dehydrogenase I (mdhi)
7RM9 · Malate dehydrogenase, cytoplasmic: “Human malate dehydrogenase I (mdhi)”. X-ray diffraction, 5 pockets (best druggability 0.67). MolNFT v1 #186688 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7RM9
- Type
- protein
- Length
- 658 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Malate dehydrogenase, cytoplasmic
- EC
- 1.1.1.37, 1.1.1.96
- UniProt
- P40925
- Pockets
- 5 · best druggability 0.67
Structure
x-ray diffraction · 2 distinct chains · 46% helix, 20% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Malate dehydrogenase, cytoplasmic (EC 1.1.1.37, 1.1.1.96) | protein | 333 | 46% helix, 20% strand | P40925 |
| B | Malate dehydrogenase, cytoplasmic (EC 1.1.1.37, 1.1.1.96) | protein | 325 | 45% helix, 20% strand | P40925 |
Ligands and binding sites
- MLI · Malonate ion · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 294 | 0.67 | 0.82 | 39 | MLI |
| 2 | 390 | 0.59 | 0.76 | 50 | empty |
| 3 | 121 | 0.52 | 0.81 | 15 | empty |
| 4 | 285 | 0.51 | 0.74 | 44 | empty |
| 5 | 163 | 0.51 | 0.78 | 21 | empty |
Interfaces
1 interface between chains.
- A–B · 1796 Ų buried · 30 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P40925
- Elsewhere: RCSB PDB 7RM9 · PDBe 7RM9 · UniProt P40925
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.